Prevalence and clonal distribution of pcpA, psrP and pilus-1 among pediatric isolates of streptococcus pneumoniae

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Selva, Laura ^a   Ciruela, Pilar ^b   Blanchette, Krystle ^c   del Amo, Eva ^a   Pallares, Roman ^d   Orihuela, Carlos J ^c   Muñoz Almagro, Carmen ^a  

^a U Integr Hosp St Joan Deu Clinic   (Spain)

^b GENERALITAT DE CATALUNYA   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; GENOMIC DNA; PENICILLIN G; PILUS 1; PNEUMOCOCCUS CHOLINE BINDING PROTEIN A; PNEUMOCOCCUS SERINE RICH PROTEIN; PNEUMOCOCCUS VACCINE; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CHILD; CLONAL VARIATION; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NASOPHARYNX; NONHUMAN; PNEUMOCOCCAL INFECTION; PREVALENCE; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; SPAIN; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

BACTERIAL PROTEINS; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; NASAL CAVITY; PHARYNGITIS; PHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RHINITIS; SPAIN; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 84864443194     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041587     Document Type: Article

References (44)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. ((2009)) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374:: 893--902.
2. Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, et al. ((2008)) Pediatric parapneumonic empyema, Spain. Emerg Infect Dis 14:: 1390--1397.
3. Li ST, Tancredi DJ, ((2010)) Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics125:: 26--33.
4. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, et al. ((2006)) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25:: 250--254.
5. Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, et al. ((2010)) Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis 201:: 32--41.
6. Pulido M, Sorvillo F, ((2010)) Declining invasive pneumococcal disease mortality in the United States, 1990-2005. Vaccine 28:: 889--892.
7. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, et al. ((2004)) Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 59:: 522--525.
8. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, et al. ((2008)) Emergence of invasive pneumococcal disease caused by non-vaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 46:: 174--182.
9. Ardanuy C, Tubau F, Pallares R, Calatayud L, Domínguez MA, et al. ((2009)) Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis 48:: 57--64.
10. Tarragó D, Aguilar L, García R, Gimenez MJ, Granizo JJ, et al. ((2011)) Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008. Antimicrob Agents Chemother 55:: 2297--2302.
11. Grijalva CG, Poehling KA, Nuorti JP, Zhu Y, Martin SW, et al. ((2006)) National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118:: 865--873.
12. Huang SS, Johnson KM, Ray GT, Wroe P, Lieu TA, et al. ((2011)) Healthcare utilization and cost of pneumococcal disease in the United States. Vaccine 29:: 3398--3412.
13. Pneumonia. Strategy overview. Bill and Melinda Gates Foundation. Available: http://www.gatesfoundation.org/global-health/Documents/pneumonia-strateg y.pdf Accessed 2011 Dec 1.
14. Pneumococcal vaccine support. Gavi Alliance. Available: http://www.gavialliance.org/support/nvs/pneumococcal/. Accessed 2011 Dec 1.
15. Obert C, Sublett J, Kaushal D, Hinojosa E, Barton T, et al. Identification of a candidate Streptococcus pneumoniae core genome and regions of diversity correlated with invasive pneumococcal disease. Infect Immun., 2006, 74: 4766-4777.
16. Rose L, Shivshankar P, Hinojosa E, Rodriguez A, Sanchez CJ, et al. ((2008)) Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. J Infect Dis198:: 375--383.
17. Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, et al. ((2006)) A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A 103:: 2857--2862.
18. Sánchez-Beato AR, López R, García JL, ((1998)) Molecular characterization of PcpA: a novel choline-binding protein of Streptococcus pneumoniae. FEMS Microbiol Lett 164:: 207--214.
19. Glover DT, Hollingshead SK, Briles DE, ((2008)) Streptococcus pneumoniae Surface Protein PcpA Elicits Protection against Lung Infection and Fatal Sepsis. Infect and Immunity 76:: 2767--2776.
20. Tarrago D, Fenoll A, Sanchez-Tatay D, Arroyo LA, Muñoz-Almagro C, et al. ((2008)) Identification of pneumococcal serotypes from culture-negative clinical specimens by novel Real-Time PCR. Clin Microbiol Infect 14:: 828--834.
21. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, et al. ((2003)) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187:: 1424--1432.
22. Sleeman KL, Griffiths D, Shackley F, ((2006)) Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 194:: 682--688.
23. National Committee for Clinical Laboratory Standards (NCCLS) (2008) Performance Standards for antimicrobial susceptibility testing: Eighteenth informational supplement. CLSI document M100-S18 (ISBN 1-5-56238-653-0) Clinical and laboratory standard institute. Wayne Pa.
24. Enright MC, Spratt BG, ((1998)) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:: 3049--3060.
25. Muñoz-Almagro C, Gala S, Selva L, Jordan I, Tarragó D, et al. ((2011)) DNA bacterial load in children and adolescents with pneumococcal pneumonia and empyema. Eur J Clin Microbiol Infect Dis 30:: 327--335.
26. Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, et al. ((2000)) Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68:: 796--800.
27. Tai SS, ((2006)) Streptococcus pneumoniae Protein Vaccine Candidates: Properties, Activities and Animal Studies. Crit Rev Microbiol 32:: 139--53.
28. Muñoz-Almagro C, Selva L, Sanchez CJ, Esteva C, de Sevilla MF, et al. ((2010)) PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type. Clin Vaccine Immunol 17:: 1672--1678.
29. Imai S, Ito Y, Ishida T, Hirai T, Ito I, et al. ((2011)) Distribution and clonal relationship of cell surface virulence genes among Streptococcus pneumoniae isolates in Japan. Clin Microbiol Infect 17:: 1409--1414.
30. Vainio A, Kaijalainen T, Hakanen AJ, Virolainen A, ((2011)) Prevalence of pilus-encoding islets and clonality of pneumococcal isolates from children with acute otitis media. Eur J Clin Microbiol Infect Dis 30:: 515--519.
31. Moschioni M, De Angelis G, Melchiorre S, Masignani V, Leibovitz E, et al. ((2010)) Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clin Microbiol Infect 16:: 1501--1504.
32. Moscoso M, García E, López R, ((2006)) Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J Bacteriol 188:: 7785--7795.
33. Kloosterman TG, Witwicki RM, van der Kooi-Pol MM, Bijlsma JJ, Kuipers OP, ((2008)) Opposite effects of Mn2+ and Zn2+ on PsaR-mediated expression of the virulence genes pcpA, prtA, and psaBCA of Streptococcus pneumoniae. J Bacteriol 190:: 5382--5393.
34. Kaur R, Casey JR, Pichichero ME, ((2011)) Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children. Pediatr Infect Dis J 30:: 645--650.
35. Hagerman A, Posfay-Barbe KM, Grillet S, Ochs MM, Brookes RH, et al. ((2011)) Failure to elicit seroresponses to pneumococcal surface proteins (pneumococcal histidine triad D, pneumococcal choline-binding protein A, and serine proteinase precursor A) in children with pneumococcal bacteraemia. Clin Microbiol Infect. In press. doi: 10.1111/j.1469-0691.2011.03629.x.
36. Brooks-Walter A, Briles DE, Hollingshead SK, ((1999)) The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun 67:: 6533--6542.
37. Orihuela CJ, Gao G, McGee M, Yu J, Francis KP, et al. ((2003)) Organ-specific models of Streptococcus pneumoniae disease. Scand J Infect Dis 35:: 647--652.
38. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, et al. ((2010)) The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 6:: e1001044.
39. Hilleringmann M, Giusti F, Baudner BC, Masignani V, Covacci A, et al. ((2008)) Pneumococcal pili are composed of protofilaments exposing adhesive clusters of Rrg A. PLoS Pathog. 4:: e1000026.
40. Harfouche C, Filippini S, Gianfaldoni C, Ruggiero P, Moschioni M, et al. ((2012)) RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies. Infect Immun 80:: 451--460.
41. Aguiar SI, Serrano I, Pinto FR, Melo-Cristino J, Ramirez M, ((2008)) The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. BMC Microbiol 8:: 41.
42. Regev-Yochay G, Hanage WP, Trzcinski K, Rifas-Shiman SL, Lee G, et al. ((2010)) Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 28:: 4842--4846.
43. Harvey RM, Stroeher UH, Ogunniyi AD, Smith-Vaughan HC, Leach AJ, et al. ((2011)) A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence. PLoS One 6:: e19650.
44. Moschioni M, Donati C, Muzzi A, Masignani V, Censini S, et al. ((2008)) Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. J Infect Dis197:: 888--896.